---
title: "LIERMAN TERRY L — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ab68f9e3-e327-511c-b0c5-5d11fc21aded
json: https://whiteintel.dev/api/public/dossier/ab68f9e3-e327-511c-b0c5-5d11fc21aded
identifier: sec:0002014677
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LIERMAN TERRY L

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002014677`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ab68f9e3-e327-511c-b0c5-5d11fc21aded  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ab68f9e3-e327-511c-b0c5-5d11fc21aded  

## Ownership & control

### Holdings / subsidiaries

- **IGC PHARMA, INC.** (director) — https://whiteintel.dev/entity/7c7cdbe1-c016-5f6c-ac95-ff0683c6933c

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LIERMAN TERRY L**. Human view: https://whiteintel.dev/entity/ab68f9e3-e327-511c-b0c5-5d11fc21aded · Structured JSON: https://whiteintel.dev/api/public/dossier/ab68f9e3-e327-511c-b0c5-5d11fc21aded._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._